Related Experiment Video
Updated: Feb 8, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation
Thomas B Davis1, Mingli Yang1, Michael J Schell2
1Gibbs Cancer Center & Research Institute, 380 Serpentine Drive, Spartanburg, SC, 29303, USA.
Abstract:
Colorectal cancer (CRC) growth and progression is frequently driven by RAS pathway activation through upstream growth factor receptor activation or through mutational activation of KRAS or BRAF. Here we describe an additional mechanism by which the RAS pathway may be modulated in CRC. PTPRS, a receptor-type protein tyrosine phosphatase, appears to regulate RAS pathway activation through ERK. PTPRS modulates ERK phosphorylation and subsequent translocation to the nucleus. Native mutations in PTPRS, present in ~10% of CRC, may reduce its phosphatase activity while increasing ERK activation and downstream transcriptional signaling.
Insights
Colorectal cancer (CRC) progression involves RAS pathway activation. Protein tyrosine phosphatase PTPRS regulates this pathway by modulating ERK signaling, with mutations potentially increasing cancer signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) growth is often driven by RAS pathway activation.
- This activation typically occurs via growth factor receptors or KRAS/BRAF mutations.
Purpose of the Study:
- To investigate an additional mechanism of RAS pathway modulation in CRC.
- To explore the role of PTPRS in regulating RAS pathway signaling.
Main Methods:
- Investigated the interaction between PTPRS and the RAS pathway.
- Analyzed PTPRS's effect on ERK phosphorylation and nuclear translocation.
- Examined the impact of native PTPRS mutations found in CRC.
Main Results:
- PTPRS, a protein tyrosine phosphatase, regulates RAS pathway activation through ERK.
- PTPRS modulates ERK phosphorylation and its subsequent translocation to the nucleus.
- Native PTPRS mutations (~10% of CRC) may decrease phosphatase activity, leading to increased ERK activation.
Conclusions:
- PTPRS represents a novel regulatory mechanism for the RAS pathway in colorectal cancer.
- PTPRS mutations may contribute to CRC progression by enhancing ERK-mediated transcriptional signaling.
More Related Videos
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
11:00Photostimulation by Femtosecond Laser Activates Extracellular-signal-regulated Kinase ERK Signaling or Mitochondrial Events in Target Cells
Published on: July 6, 2019
Related Concept Videos
X-Inactivation
Cancer Prevention
Some...
Activation and Inactivation of G Proteins
The Ras Gene
Ras is a...
Regulation of Nuclear Protein Sorting
GTPases and their Regulation
Large G-proteins,...